<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Therapies of uncertain benefit in basic and advanced cardiac life support</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Therapies of uncertain benefit in basic and advanced cardiac life support</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Therapies of uncertain benefit in basic and advanced cardiac life support</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan Elmer, MD, MS, FNCS</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ron M Walls, MD, FRCPC, FAAEM</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard L Page, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan Grayzel, MD, FAAEM</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 26, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The modern approach to advanced cardiac life support (ACLS) reflects an increasingly rigorous approach to resuscitation science [<a href="#rid1">1-3</a>]. Nevertheless, while a few ACLS treatments are well supported by evidence, numerous controversies and uncertainties in the management of sudden cardiac arrest (SCA) persist.</p><p>Selected controversies related to the techniques and medications used in the performance of basic and advanced life support are discussed here. The performance of basic and advanced life support and the evidence supporting ACLS are reviewed separately. (See  <a class="medical medical_review" href="/d/html/278.html" rel="external">"Advanced cardiac life support (ACLS) in adults"</a> and  <a class="medical medical_review" href="/d/html/272.html" rel="external">"Adult basic life support (BLS) for health care providers"</a> and  <a class="medical medical_review" href="/d/html/1028.html" rel="external">"Supportive data for advanced cardiac life support in adults with sudden cardiac arrest"</a>.)</p><p class="headingAnchor" id="H1190179455"><span class="h1">MEDICATIONS USED DURING CARDIOPULMONARY RESUSCITATION</span><span class="headingEndMark"> — </span>Medications commonly used in the management of cardiac arrest and life-threatening arrhythmias are reviewed separately; individual and combinations of medications of uncertain benefit or not commonly used but under investigation are discussed here. (See  <a class="medical medical_review" href="/d/html/278.html" rel="external">"Advanced cardiac life support (ACLS) in adults", section on 'Medications used during CPR'</a>.)</p><p class="headingAnchor" id="H3015477529"><span class="h2">Epinephrine: Dosing and long-term outcomes</span><span class="headingEndMark"> — </span>We agree with the ACLS recommendation to administer standard-dose intravenous (IV)/intraosseous (IO) <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>, 1 mg every three to five minutes during cardiopulmonary resuscitation (CPR). There is no role for high-dose epinephrine. </p><p><a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">Epinephrine</a> is a potent vasoconstrictor that may improve coronary and cerebral perfusion and oxygen delivery, thereby promoting return of spontaneous circulation (ROSC) and minimizing hypoxic-ischemic brain injury in patients with sudden cardiac arrest (SCA). </p><p>Improved ROSC and survival to hospital admission after <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> administration must be followed by delivery of excellent post-arrest care to maximize the likelihood that these short-term benefits translate to long-term favorable recovery. (See  <a class="medical medical_review" href="/d/html/13838.html" rel="external">"Initial assessment and management of the adult post-cardiac arrest patient"</a> and  <a class="medical medical_review" href="/d/html/127223.html" rel="external">"Intensive care unit management of the intubated post-cardiac arrest adult patient"</a>.)</p><p>The 1 mg dose of <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> recommended in ACLS is extrapolated from early animal models, with little evidence to support its superiority to other dosing regimens:</p><p class="bulletIndent1"><span class="glyph">●</span>A randomized controlled trial including 650 adults who suffered in- or out-of-hospital cardiac arrest compared standard-dose <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> (1 mg) with high-dose epinephrine (7 mg), each administered up to five times at five-minute intervals during CPR [<a href="#rid4">4</a>]. There was no difference in ROSC or survival to hospital discharge between arms, with worse outcomes in select subgroups of patients receiving high-dose epinephrine (eg, those with &gt;10 minutes from collapse to medication administration).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A randomized controlled trial including 816 adults resuscitated from out-of-hospital cardiac arrest compared standard-dose <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> (1 mg), high-dose epinephrine (15 mg), and high-dose <a class="drug drug_general" data-topicid="9709" href="/d/drug information/9709.html" rel="external">norepinephrine</a> (11 mg) [<a href="#rid5">5</a>]. High-dose epinephrine improved prehospital ROSC and survival to hospital admission compared with standard-dose epinephrine (13 versus 8 percent and 18 versus 10 percent, respectively). There was no difference in survival to hospital discharge, with a non-significant trend towards worse functional outcomes at hospital discharge in the high-dose epinephrine group.</p><p></p><p>Beyond the uncertainty about the optimal dose of <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>, it remains unclear whether any epinephrine administration improves long-term patient outcomes following SCA:</p><p class="bulletIndent1"><span class="glyph">●</span>The randomized controlled PARAMEDIC2 trial of 8014 adult patients with out-of-hospital cardiac arrest compared up to 10 doses of parenteral <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> versus placebo given every three to five minutes during standard ACLS [<a href="#rid6">6</a>]. Compared with placebo, epinephrine resulted in significantly better survival to hospital admission (24 versus 8 percent) and 30-day survival (3.2 versus 2.4 percent, p = 0.02) but did not improve functionally favorable survival at 30 days.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A cost-effectiveness analysis of PARAMEDIC2 found improved survival to hospital admission in the <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> arm also increased the number of organs donated after in-hospital death and found epinephrine administration to be cost effective after accounting for this societal benefit [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A systematic review and meta-analysis of five randomized controlled trials of <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> versus placebo during cardiac arrest found epinephrine to be associated with improved ROSC (odds ratio [OR]  3.1, 95% CI  2.16-4.45) and survival to hospital admission (OR 2.52, 95% CI  1.63-3.88) but not survival to discharge or neurological outcomes [<a href="#rid8">8</a>].</p><p></p><p class="headingAnchor" id="H114490141"><span class="h2">Antidysrhythmics</span><span class="headingEndMark"> — </span>We agree with ACLS recommendations that <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a> or <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> may be reasonable treatments for shock-refractory ventricular tachycardia (VT)/ventricular fibrillation (VF), especially in patients with witnessed arrest, and may be administered to improve the chance of successful defibrillation [<a href="#rid9">9</a>]. Nevertheless, while study results suggest higher survival to hospital admission, evidence of improved functional outcomes among patients receiving these medications is lacking:</p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial compared <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a> 300 mg IV versus placebo in 504 patients with shock-refractory VT/VF in Seattle and King County, Washington (United States) [<a href="#rid10">10</a>]. Survival to hospital admission was better in the amiodarone group than the placebo group (44 versus 34 percent). Bradycardia and hypotension were also more common in the amiodarone group, although it was unclear whether this was due primarily to the study drug or choice of diluent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial compared <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a> 5 mg/kg versus <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> 1.5mg/kg in 347 patients with shock-refractory VT/VF in out-of-hospital cardiac arrest [<a href="#rid11">11</a>]. Survival to hospital admission was better for patients receiving amiodarone compared with lidocaine (22.8 versus 12.0 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a randomized trial of 3026 patients with shock-refractory out-of-hospital VT/VF arrest, survival to hospital admission was better in the groups treated with <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a> or <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> compared with the placebo group (45.7 versus 47.0 versus 36.7 percent) [<a href="#rid12">12</a>]. However, survival to hospital discharge (primary outcome) and functionally favorable survival at discharge did not differ across treatment groups. Of the 1934 subjects with witnessed collapse (for whom time to drug administration was likely shorter), survival was better with either amiodarone or lidocaine compared with placebo (27.7 versus 27.8 versus 22.7 percent).</p><p></p><p class="headingAnchor" id="H130028156"><span class="h2">Vasopressin, glucocorticoid, and epinephrine</span><span class="headingEndMark"> — </span>Studies of combinations of these medications or of glucocorticoid alone for the treatment of cardiac arrest have produced unclear results. Further study is needed before it is known whether such combination therapies have a justified role in clinical practice:</p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial of 268 consecutive cardiac arrest patients reported improved survival to hospital discharge with good neurologic status in patients treated initially with the combination of <a class="drug drug_general" data-topicid="10039" href="/d/drug information/10039.html" rel="external">vasopressin</a>, <a class="drug drug_general" data-topicid="9639" href="/d/drug information/9639.html" rel="external">methylprednisolone</a>, and <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> (VME) compared with those treated with placebo plus epinephrine, but only 25 patients achieved the primary outcome (18 out of 130 [13.9 percent] in the VME group versus 7 out of 138 [5.1 percent] in the placebo group (OR 3.28; 95 percent CI 1.17-9.20) [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A trial of 501 patients randomly assigned to treatment with <a class="drug drug_general" data-topicid="10039" href="/d/drug information/10039.html" rel="external">vasopressin</a> and <a class="drug drug_general" data-topicid="9639" href="/d/drug information/9639.html" rel="external">methylprednisolone</a> or placebo reported an increased rate of ROSC in the intervention group but no difference in 30-day, six-month, or one-year survival rates or functionally favorable recovery [<a href="#rid14">14,15</a>]. A post hoc analysis found no difference in early post-arrest hemodynamics, vasopressor dependence, gas exchange, or lactate level between groups [<a href="#rid16">16</a>]. These patients were all inpatient cardiac arrests.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of 11 studies involving 2273 cardiac arrest patients found that treatment with glucocorticoid was not associated with improved neurologic outcomes (OR 1.13, 95% CI 0.81-1.58) or overall survival to hospital discharge (OR 1.29, 95% CI 0.74-2.26) [<a href="#rid17">17</a>].</p><p></p><p class="headingAnchor" id="H2511175356"><span class="h2">Other medications</span></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8983" href="/d/drug information/8983.html" rel="external">Atropine</a> –<strong> </strong>Atropine is a potent anticholinergic that reverses cholinergic-mediated bradycardia and conduction delays and is indicated for symptomatic bradycardia. We agree with ACLS recommendations that there is no role for atropine in the management of cardiac arrest. Intra-arrest atropine administration has not been evaluated in randomized trials. In 2010, a paucity of evidence supporting efficacy led the American Heart Association (AHA) to remove atropine from algorithms for resuscitation of pulseless electrical activity and asystole [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/d/html/278.html" rel="external">"Advanced cardiac life support (ACLS) in adults", section on 'Bradycardia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9928" href="/d/drug information/9928.html" rel="external">Sodium bicarbonate</a> – Sodium bicarbonate expands circulating blood volume and can correct acidosis that develops during prolonged cardiac arrest. We agree with ACLS recommendations that sodium bicarbonate should not be administered routinely during cardiac arrest. At least four randomized trials and numerous observational studies have evaluated the effect of intra-arrest sodium bicarbonate administration on patient outcomes with conflicting results [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="9928" href="/d/drug information/9928.html" rel="external">Sodium bicarbonate</a> may benefit patients who sustain SCA due to hyperkalemia, acidosis, or overdose from medications such as tricyclic antidepressants, for which sodium bicarbonate is an indicated therapy. (See  <a class="medical medical_review" href="/d/html/295.html" rel="external">"Tricyclic antidepressant poisoning", section on 'Sodium bicarbonate for cardiac toxicity'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Calcium – <a class="drug drug_general" data-topicid="9186" href="/d/drug information/9186.html" rel="external">Calcium chloride</a> is a vasopressor and inotrope. Calcium chloride should not be routinely administered during cardiac arrest but may be indicated in some special circumstances (eg, hyperkalemia, calcium channel blocker poisoning, hypocalcemia). (See  <a class="medical medical_review" href="/d/html/2332.html" rel="external">"Treatment and prevention of hyperkalemia in adults"</a> and  <a class="medical medical_review" href="/d/html/331.html" rel="external">"Calcium channel blocker poisoning"</a>.)</p><p></p><p class="bulletIndent1">A randomized trial of <a class="drug drug_general" data-topicid="9186" href="/d/drug information/9186.html" rel="external">calcium chloride</a> versus placebo during resuscitation of out-of-hospital cardiac arrest patients was stopped early because of a trend towards reduced rates of ROSC in patients receiving calcium [<a href="#rid20">20</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Beta blocker</strong> – Sympathetic blockade using beta blockers has been suggested as a treatment for refractory VT/VF arrest when primary anti-arrhythmics and defibrillation are unsuccessful. Although some studies show benefit, more definitive research is needed to determine if rapid-acting agents, such as <a class="drug drug_general" data-topicid="9420" href="/d/drug information/9420.html" rel="external">esmolol</a> or <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a>, are effective<em> </em>[<a href="#rid21">21</a>]<em>.</em></p><p></p><p class="headingAnchor" id="H1007488049"><span class="h2">Fibrinolysis</span><span class="headingEndMark"> — </span>We agree with the ACLS recommendation against routine use of fibrinolytics for patients in cardiac arrest. Thrombolytic therapy may have a role when pulmonary embolism is the presumed or likely cause of SCA, and it is used in some cases for management of acute coronary syndrome or stroke. These indications are reviewed separately. (See  <a class="medical medical_review" href="/d/html/8259.html" rel="external">"Approach to thrombolytic (fibrinolytic) therapy in acute pulmonary embolism: Patient selection and administration"</a> and  <a class="medical medical_review" href="/d/html/55.html" rel="external">"Acute ST-elevation myocardial infarction: The use of fibrinolytic therapy"</a> and  <a class="medical medical_review" href="/d/html/115775.html" rel="external">"Approach to reperfusion therapy for acute ischemic stroke"</a>.)</p><p>Acute coronary syndrome and pulmonary embolism account for an estimated 50 to 70 percent of cases of SCA that go on to autopsy after failed resuscitation [<a href="#rid22">22-24</a>]. Although fibrinolysis would seem to be a promising treatment for refractory SCA, studies have failed to demonstrate benefit [<a href="#rid25">25</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A large, prospective multicenter trial (Thrombolysis in Cardiac Arrest, or TROICA, trial) was stopped early when preliminary analyses of 1050 patients failed to detect a difference between those receiving <a class="drug drug_general" data-topicid="9955" href="/d/drug information/9955.html" rel="external">tenecteplase</a> and those receiving placebo in the primary endpoint of 30-day survival [<a href="#rid26">26</a>]. There was also no significant difference in the secondary endpoints of hospital admission, ROSC, 24-hour survival, survival to hospital discharge, or neurologic outcome.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another randomized trial found no difference in survival to hospital discharge among patients with SCA and pulseless electrical activity treated with tissue plasminogen activator (t-PA) in addition to standard resuscitation (n = 117) compared with patients treated with standard resuscitation alone (n = 116) [<a href="#rid27">27</a>]. Patient characteristics in the two groups were similar.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A prospective trial of 90 out-of-hospital SCA patients demonstrated a significant improvement in ROSC (68 versus 44 percent) and survival to intensive care unit (ICU) admission (48 versus 30 percent) in patients treated with recombinant t-PA compared with controls who received standard treatment, but no significant differences were noted in 24-hour survival or survival to hospital discharge [<a href="#rid24">24</a>].</p><p></p><p>Other studies have failed to find statistically significant benefit from fibrinolytic therapy in SCA [<a href="#rid24">24,28,29</a>].</p><p class="headingAnchor" id="H3174127690"><span class="h2">Neuroprotective medications</span><span class="headingEndMark"> — </span>Mechanisms of hypoxic-ischemic brain injury are complex and develop rapidly during cardiac arrest. There is interest in developing pharmacologic therapies that slow or prevent brain injury when administered during or shortly after cardiac arrest. Randomized trials have evaluated barbiturates, glucocorticoids, calcium channel blockers, benzodiazepines, and other drug classes [<a href="#rid30">30-35</a>]. As yet, no pharmacologic interventions providing effective neuroprotection have been identified.</p><p class="headingAnchor" id="H1993365573"><span class="h2">Vascular and intraosseous access for medication administration</span><span class="headingEndMark"> — </span>High-quality chest compressions and early defibrillation are cornerstones of effective CPR. Adjunctive medications including <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>, <a class="drug drug_general" data-topicid="8983" href="/d/drug information/8983.html" rel="external">atropine</a>, and antidysrhythmic have theoretical mechanistic benefits but a paucity of data, as reviewed above. It is unclear whether potential benefits outweigh adverse drug effects or the potential for establishing vascular access and medication administration to distract from high-quality CPR.</p><p>Routinely obtaining vascular access and intravascular medication administration during ACLS is of dubious benefit at the population level. The pathophysiology of SCA is heterogeneous, and it is likely that vascular access is beneficial in some patients but not others. As an example, patients with pulseless electrical activity due to hypovolemic or hemorrhagic shock are likely to benefit from intravascular volume expansion and transfusion, respectively. If pursued, establishing vascular access and medication administration must not distract from high-quality chest compressions and early defibrillation of shockable rhythms:</p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial of 851 adults treated by emergency medical service providers after out-of-hospital cardiac arrest compared ACLS with IV drug administration to ACLS without IV drug administration [<a href="#rid36">36</a>]. Medication administration improved rates of ROSC (40 versus 25 percent) and survival to ICU admission (30 versus 20 percent), but there was no difference in survival to hospital discharge (10.5 versus 9.2 percent), functionally favorable survival, or one-year survival.</p><p></p><p>Multiple observational studies and several post hoc analyses of randomized trials have compared IV to interosseous (IO) vascular access during CPR with mixed results:</p><p class="bulletIndent1"><span class="glyph">●</span>In a secondary analysis of the Resuscitation Outcomes Consortium Continuous Chest Compression Trial including 3068 patients with attempted IO access and 16,663 patients with attempted IV access, IO access was independently associated with lower rates of ROSC (OR 0.80; 95% CI 0.71-0.89) but no difference in survival to hospital discharge or functionally favorable survival [<a href="#rid37">37</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a secondary analysis of the Resuscitation Outcomes Consortium <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">Amiodarone</a>, <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">Lidocaine</a> or Placebo Study including 3019 patients, IV amiodarone and IV lidocaine resulted in significantly better risk-adjusted survival to hospital discharge compared with placebo (adjusted risk ratio 1.29 [95% CI 1.06-1.50] and 1.21 [95% CI 1.02-1.45], respectively). By contrast, neither amiodarone nor lidocaine administered by IO access improved risk-adjusted survival to hospital discharge compared with placebo [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a secondary analysis of the PARAMEDIC2 trial of <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> versus placebo for out-of-hospital cardiac arrest, including 7317 subjects of whom 2237 (30 percent) received the study drug via the IO route, there was no interaction detected between route of administration and treatment arm in models predicting ROSC at hospital arrival, survival at 30 days, or favorable functional status at 30 days post-arrest [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A systematic review and meta-analysis of observational studies including 111,746 adult patients resuscitated from cardiac arrest found no difference in functionally favorable survival to hospital discharge in patients with IV versus IO vascular access [<a href="#rid40">40</a>].</p><p></p><p class="headingAnchor" id="H108941904"><span class="h1">MECHANICAL APPROACHES TO CARDIOPULMONARY RESUSCITATION</span><span class="headingEndMark"> — </span>High-quality chest compressions optimize coronary and cerebral perfusion during cardiac arrest, promoting return of spontaneous circulation (ROSC) and minimizing hypoxic-ischemic brain injury. Multiple approaches to increase the benefits of closed-chest compression have been investigated, but none has demonstrated consistent benefit.</p><p class="headingAnchor" id="H2045330051"><span class="h2">Inspiratory impedance threshold devices</span><span class="headingEndMark"> — </span>The ACLS Guidelines state that routine use of an inspiratory impedance threshold device (ITD) during conventional cardiopulmonary resuscitation (CPR) is not recommended. When equipment and trained personnel are available, use of an ITD during active compression-decompression CPR (ACD-CPR) may be reasonable.</p><p>An ITD is designed to generate negative intrathoracic pressure during passive or active decompression of the chest wall, thereby increasing venous return to the heart (ie, preload) during CPR. The device is a plastic appliance with a silicone diaphragm placed between the airway and the bag ventilator. The ITD permits positive-pressure ventilation and exhalation but prevents the flow of air into the patient's airway during chest wall relaxation. Employing an ITD during active or passive decompression of the chest with CPR reduces intrathoracic pressures and improves both preload and myocardial perfusion.</p><p>The ITD is effective at generating negative intrathoracic pressures in patients ventilated using a bag-mask or invasive airway, but this has not been demonstrated to improve clinical outcomes [<a href="#rid41">41</a>]. When the ITD is used as part of bag-mask ventilation, it is crucial to maintain a good mask seal, and for this reason, a two-person ventilation technique is recommended. Regardless of the selected approach to airway management, ITD use should not affect standard CPR guidelines, such as the compression to ventilation ratio (30 to 2) or provision of high-quality CPR. (See  <a class="medical medical_review" href="/d/html/267.html" rel="external">"Basic airway management in adults"</a>.)</p><p>Clinical trials of ITDs have reported mixed results:</p><p class="bulletIndent1"><span class="glyph">●</span>In a multicenter trial in which 400 out-of-hospital cardiac arrest patients received treatment with ACD-CPR and were randomly assigned to ventilation incorporating either an active ITD or a sham device, survival at 24 hours (primary endpoint) was achieved in 32 percent of patients in the ITD group and 22 percent in the sham group (odds ratio [OR] 1.64; 95% CI 1.07-2.6) [<a href="#rid42">42</a>]. There was no difference in survival to hospital discharge (4 percent for the ITD group versus 5 percent for the sham group) or functionally favorable survival at discharge (3 percent for the ITD group versus 0.5 percent for the sham group).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a multicenter prospective trial of 8718 emergency medical services-treated patients resuscitated from out-of-hospital cardiac arrest and randomly assigned to treatment with an ITD or a sham device, no significant difference was found in functionally favorable survival (5.8 percent in the ITD group versus 6 percent in the sham group) [<a href="#rid43">43</a>]. In addition, there was no difference between groups in adverse events or in secondary outcomes, including ROSC on arrival or survival to hospital discharge.</p><p></p><p class="headingAnchor" id="H3249060543"><span class="h2">Active compression-decompression CPR</span><span class="headingEndMark"> — </span>ACD-CPR is a method of chest compression that uses a suction device to convert the passive recoil of the chest wall into active expansion, thereby enhancing venous return. According to the ACLS Guidelines, there is insufficient evidence to recommend for or against the use of ACD-CPR.</p><p>Although preliminary studies in swine and humans using this method reported increased cerebral and myocardial perfusion and improved stroke volume [<a href="#rid44">44-46</a>], the results of subsequent clinical trials have been mixed. A meta-analysis of 10 randomized and quasi-randomized trials (most involving out-of-hospital cardiac arrest) found no significant benefit from ACD-CPR compared with standard CPR in any patient-important outcome, including immediate mortality, survival to hospital discharge, and neurologic function [<a href="#rid47">47</a>]. In addition, the meta-analysis found no significant difference in major complications (eg, rib or sternal fractures, hemothorax, pneumothorax), although skin trauma and ecchymosis were more common in the ACD-CPR group.</p><p>One multicenter randomized trial of patients with out-of-hospital cardiac arrest, not included in the meta-analysis described above, reported that 75 of 849 patients (9 percent) treated with both ACD-CPR and an ITD survived to hospital discharge compared with 47 of 813 patients (6 percent) treated with standard CPR (OR 1.58; 95% CI 1.07-2.36) [<a href="#rid48">48</a>]. The trial was stopped early because of enrollment and funding difficulties. Other challenges with this trial include the difficulty of determining the impact of the device's metronome and force gauge (used only in the intervention arm) on the quality of CPR independent of ACD-CPR and the inability to control for the contribution of the ITD to the outcome.</p><p class="headingAnchor" id="H4130794855"><span class="h2">Mechanical compression devices</span><span class="headingEndMark"> — </span>Devices for mechanical chest compression do not improve patient-important outcomes and may be associated with complications [<a href="#rid49">49,50</a>]. Therefore, they should not be used routinely. In settings where it may be difficult or dangerous to perform or sustain high-quality chest compressions (eg, few rescuers, prolonged CPR, CPR during transport, CPR during cardiac catheterization [<a href="#rid51">51,52</a>]), these devices may be useful.</p><p>Researchers have developed mechanical devices that perform chest compressions and generate artificial circulation in much the same way as manually performed chest compressions. Two basic types of devices exist. One uses a load-distributing band wrapped around the chest that rhythmically squeezes the chest circumferentially. A second employs a piston placed on the sternum that compresses the chest in the anteroposterior plane. Both devices deliver closed chest compressions automatically, enabling rescuers to perform other interventions, minimizing interruptions in the performance of compressions, and eliminating the risk of decreased perfusion due to rescuer fatigue.</p><p>Three major randomized trials of these devices and a meta-analysis have been performed:</p><p class="bulletIndent1"><span class="glyph">●</span>A multicenter randomized trial reported no statistically significant differences between patients resuscitated with a piston-type mechanical chest compression device (n = 1300) compared with manual CPR (n = 1289) in survival at four hours (307 [23.6 percent] versus 305 [23.7 percent]) or functionally favorable survival at six months (98 [7.5 percent] versus 82 [6.4 percent]) [<a href="#rid53">53</a>]. Two issues that complicate the interpretation of the study results are the atypical resuscitation protocol used in the intervention arm and the additional training provided to participants.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A multicenter randomized trial involving 4231 cardiac arrest patients compared the effectiveness of a load-distributing band mechanical compression device versus manual CPR and reported no statistically significant difference in survival to hospital admission or discharge [<a href="#rid54">54</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial involving 4471 cardiac arrest patients reported no significant difference in 30-day survival between patients treated with a piston-type mechanical chest compression device and patients managed with manual CPR [<a href="#rid55">55</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis including 12,908 patients with cardiac arrest enrolled in one of seven randomized trials comparing mechanical CPR versus manual CPR found that patients who had received manual CPR had better survival to hospital discharge or 30 days (OR 1.40; 95% CI 1.09-1.94) and functionally favorable survival at discharge or 30 days (OR 1.51; 95% CI 1.06-2.39) [<a href="#rid49">49</a>]. Compared with load-distributing band mechanical compression, manual compressions had a lower risk of pneumothorax or hematoma formation.</p><p></p><p class="headingAnchor" id="H850149989"><span class="h2">Performance of interposed abdominal compression CPR</span><span class="headingEndMark"> — </span>Preliminary data suggest that interposed abdominal compression cardiopulmonary resuscitation (IAC-CPR) when used in the in-hospital setting and performed by trained rescuers may be effective, and the ACLS Guidelines state that the technique may be used in this setting. However, the effectiveness of IAC-CPR for achieving improved survival without significant neurologic deficits remains unproven, and further study is needed.</p><p>IAC-CPR refers to the application of external chest compressions with interposed midabdominal compressions performed by a second rescuer during the upstroke of the chest compression. Multiple animal studies have shown that IAC-CPR can increase systolic and diastolic blood pressure, improving myocardial and cerebral perfusion [<a href="#rid56">56</a>].</p><p>A meta-analysis identified 38 peer-reviewed studies of IAC-CPR (25 were animal or mechanical model studies) of which 34 reported significant benefit over standard CPR based primarily on ROSC (a problematic endpoint); two found no difference in outcome, and two found IAC-CPR to be inferior to standard CPR [<a href="#rid57">57</a>]. The studies reported a single adverse event (case of likely traumatic pancreatitis) [<a href="#rid58">58</a>]. Of four randomized trials included, three were in-hospital studies, all of which found an increased rate of ROSC in the IAC-CPR arm [<a href="#rid59">59,60</a>], with one study reporting improved survival to discharge [<a href="#rid61">61</a>]. The lone prehospital study found no significant difference in ROSC [<a href="#rid62">62</a>].</p><p class="headingAnchor" id="H3947176327"><span class="h1">OTHER ASPECTS OF RESUSCITATION</span></p><p class="headingAnchor" id="H621725235"><span class="h2">Airway management</span><span class="headingEndMark"> — </span>Airway management during cardiopulmonary resuscitation (CPR) should never interfere with provision of high-quality chest compressions and rapid defibrillation of shockable rhythms. Bag-valve-mask (BVM) ventilation or placement of a supraglottic airway are reasonable approaches to intra-arrest airway management and generally preferred to endotracheal intubation. If intubation is performed, it must be done by an experienced provider, ideally require less than 10 seconds to complete, be performed without interruption of chest compressions, and occur only after all other essential resuscitative maneuvers have been initiated. (See  <a class="medical medical_review" href="/d/html/278.html" rel="external">"Advanced cardiac life support (ACLS) in adults", section on 'Airway management'</a>.)</p><p>Options for intra-arrest airway management include making no intervention, BVM ventilation, supraglottic airway insertion, and endotracheal intubation. The optimal approach remains uncertain:</p><p class="bulletIndent1"><span class="glyph">●</span>In a randomized trial of BVM ventilation (1020 patients) versus tracheal intubation (1023 patients) for prehospital management of out-of-hospital cardiac arrest in France and Belgium, functionally favorable survival at 28 days did not differ between groups (4.3 percent for BVM compared with 4.2 percent for tracheal intubation) [<a href="#rid63">63</a>]. The trial failed to meet the prespecified criteria for noninferiority. Ambulance teams in these countries include physicians with training in intubation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a multicenter cluster randomized trial of a supraglottic airway device (4886 patients) versus tracheal intubation (4410 patients) for prehospital airway management of out-of-hospital cardiac arrest in England, functionally favorable survival at hospital discharge, 30 days, three months, and six months did not differ between groups [<a href="#rid64">64</a>]. However, initial ventilation success occurred more commonly in the supraglottic airway group (87 versus 79 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a multicenter cluster-crossover trial of a laryngeal tube (1505 patients) versus tracheal intubation (1499 patients) for prehospital airway management of out-of-hospital cardiac arrest in the United States, 72-hour survival, survival to discharge, and functionally favorable survival were each better in the laryngeal tube group [<a href="#rid65">65</a>].</p><p></p><p class="headingAnchor" id="H375121079"><span class="h2">Use of transcutaneous pacing in asystole</span><span class="headingEndMark"> — </span>We concur with the ACLS Guidelines, which state that transcutaneous pacing (TCP) is not recommended for management of asystole or pulseless electrical activity. The use of TCP for emergency treatment of symptomatic bradycardia is discussed separately. (See  <a class="medical medical_review" href="/d/html/278.html" rel="external">"Advanced cardiac life support (ACLS) in adults", section on 'Bradycardia'</a>.)</p><p>TCP is the delivery of a rhythmic electrical current to induce electrical conduction and mechanical activity in the heart. The current is conducted between two electrodes placed on the skin in a manner that ensures the heart lies between them.</p><p>Multiple studies of TCP performed in the late 1980s found no significant survival benefit among patients in cardiac arrest from asystole or bradyasystole [<a href="#rid66">66-70</a>]. A larger, subsequent randomized trial of TCP in out-of-hospital asystolic cardiac arrest also found no benefit [<a href="#rid71">71</a>]. A systematic review found no evidence to support the use of TCP for out-of-hospital bradyasystolic arrest but found insufficient evidence to determine its role with symptomatic bradycardia [<a href="#rid72">72</a>].</p><p class="headingAnchor" id="H1710763600"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/117075.html" rel="external">"Society guideline links: Basic and advanced cardiac life support in adults"</a>.)</p><p class="headingAnchor" id="H98779146"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of cardiac arrest</strong> – Standard management of patients in sudden cardiac arrest (SCA), cardiac arrhythmia, and related critical illness is thoroughly discussed in several UpToDate topic reviews: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Advanced cardiac life support (ACLS) (see  <a class="medical medical_review" href="/d/html/278.html" rel="external">"Advanced cardiac life support (ACLS) in adults"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Basic life support (BLS) (see  <a class="medical medical_review" href="/d/html/272.html" rel="external">"Adult basic life support (BLS) for health care providers"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Post-cardiac arrest management (see  <a class="medical medical_review" href="/d/html/13838.html" rel="external">"Initial assessment and management of the adult post-cardiac arrest patient"</a> and  <a class="medical medical_review" href="/d/html/127223.html" rel="external">"Intensive care unit management of the intubated post-cardiac arrest adult patient"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Airway management (see  <a class="medical medical_review" href="/d/html/267.html" rel="external">"Basic airway management in adults"</a> and  <a class="medical medical_review" href="/d/html/106475.html" rel="external">"Extraglottic devices for emergency airway management in adults"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Therapies and interventions of uncertain benefit</strong> – A number of potential therapies and interventions for patients with SCA continue to be the subject of clinical study. Such therapies include resuscitation techniques, mechanical devices, and medications. Therapies that are the subject of clinical research but are not generally accepted as part of standard resuscitation are reviewed above:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Medications (see <a class="local">'Medications used during cardiopulmonary resuscitation'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mechanical devices and approaches for cardiopulmonary resuscitation (CPR) (see <a class="local">'Mechanical approaches to cardiopulmonary resuscitation'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Airway management and other interventions (see <a class="local">'Other aspects of resuscitation'</a> above)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Panchal AR, Bartos JA, Cabañas JG, et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2020; 142:S366.</a></li><li><a class="nounderline abstract_t">Soar J, Böttiger BW, Carli P, et al. European Resuscitation Council Guidelines 2021: Adult advanced life support. Resuscitation 2021; 161:115.</a></li><li><a class="nounderline abstract_t">Soar J, Berg KM, Andersen LW, et al. Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation 2020; 156:A80.</a></li><li><a class="nounderline abstract_t">Stiell IG, Hebert PC, Weitzman BN, et al. High-dose epinephrine in adult cardiac arrest. N Engl J Med 1992; 327:1045.</a></li><li><a class="nounderline abstract_t">Callaham M, Madsen CD, Barton CW, et al. A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest. JAMA 1992; 268:2667.</a></li><li><a class="nounderline abstract_t">Perkins GD, Ji C, Deakin CD, et al. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. N Engl J Med 2018; 379:711.</a></li><li><a class="nounderline abstract_t">Achana F, Petrou S, Madan J, et al. Cost-effectiveness of adrenaline for out-of-hospital cardiac arrest. Crit Care 2020; 24:579.</a></li><li><a class="nounderline abstract_t">Kempton H, Vlok R, Thang C, et al. Standard dose epinephrine versus placebo in out of hospital cardiac arrest: A systematic review and meta-analysis. Am J Emerg Med 2019; 37:511.</a></li><li><a class="nounderline abstract_t">Panchal AR, Berg KM, Kudenchuk PJ, et al. 2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2018; 138:e740.</a></li><li><a class="nounderline abstract_t">Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999; 341:871.</a></li><li><a class="nounderline abstract_t">Dorian P, Cass D, Schwartz B, et al. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002; 346:884.</a></li><li><a class="nounderline abstract_t">Kudenchuk PJ, Brown SP, Daya M, et al. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. N Engl J Med 2016; 374:1711.</a></li><li><a class="nounderline abstract_t">Mentzelopoulos SD, Malachias S, Chamos C, et al. Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial. JAMA 2013; 310:270.</a></li><li><a class="nounderline abstract_t">Andersen LW, Isbye D, Kjærgaard J, et al. Effect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA 2021; 326:1586.</a></li><li><a class="nounderline abstract_t">Granfeldt A, Sindberg B, Isbye D, et al. Effect of vasopressin and methylprednisolone vs. placebo on long-term outcomes in patients with in-hospital cardiac arrest a randomized clinical trial. Resuscitation 2022; 175:67.</a></li><li><a class="nounderline abstract_t">Andersen LW, Holmberg MJ, Høybye M, et al. Vasopressin and methylprednisolone and hemodynamics after in-hospital cardiac arrest - A post hoc analysis of the VAM-IHCA trial. Resuscitation 2023; 191:109922.</a></li><li><a class="nounderline abstract_t">Zhou FW, Liu C, Li DZ, et al. Efficacy and safety of corticosteroid therapy in patients with cardiac arrest: A meta-analysis of randomized controlled trials. Am J Emerg Med 2024; 75:111.</a></li><li><a class="nounderline abstract_t">Neumar RW, Otto CW, Link MS, et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S729.</a></li><li><a class="nounderline abstract_t">Alshahrani MS, Aldandan HW. Use of sodium bicarbonate in out-of-hospital cardiac arrest: a systematic review and meta-analysis. Int J Emerg Med 2021; 14:21.</a></li><li><a class="nounderline abstract_t">Vallentin MF, Granfeldt A, Meilandt C, et al. Effect of Intravenous or Intraosseous Calcium vs Saline on Return of Spontaneous Circulation in Adults With Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA 2021; 326:2268.</a></li><li><a class="nounderline abstract_t">Gottlieb M, Dyer S, Peksa GD. Beta-blockade for the treatment of cardiac arrest due to ventricular fibrillation or pulseless ventricular tachycardia: A systematic review and meta-analysis. Resuscitation 2020; 146:118.</a></li><li><a class="nounderline abstract_t">Silfvast T. Cause of death in unsuccessful prehospital resuscitation. J Intern Med 1991; 229:331.</a></li><li><a class="nounderline abstract_t">Spaulding CM, Joly LM, Rosenberg A, et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 1997; 336:1629.</a></li><li><a class="nounderline abstract_t">Böttiger BW, Bode C, Kern S, et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 2001; 357:1583.</a></li><li><a class="nounderline abstract_t">Wang Y, Wang M, Ni Y, et al. Can Systemic Thrombolysis Improve Prognosis of Cardiac Arrest Patients During Cardiopulmonary Resuscitation? A Systematic Review and Meta-Analysis. J Emerg Med 2019; 57:478.</a></li><li><a class="nounderline abstract_t">Böttiger BW, Arntz HR, Chamberlain DA, et al. Thrombolysis during resuscitation for out-of-hospital cardiac arrest. N Engl J Med 2008; 359:2651.</a></li><li><a class="nounderline abstract_t">Abu-Laban RB, Christenson JM, Innes GD, et al. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002; 346:1522.</a></li><li><a class="nounderline abstract_t">Stadlbauer KH, Krismer AC, Arntz HR, et al. Effects of thrombolysis during out-of-hospital cardiopulmonary resuscitation. Am J Cardiol 2006; 97:305.</a></li><li><a class="nounderline abstract_t">Lederer W, Lichtenberger C, Pechlaner C, et al. Long-term survival and neurological outcome of patients who received recombinant tissue plasminogen activator during out-of-hospital cardiac arrest. Resuscitation 2004; 61:123.</a></li><li><a class="nounderline abstract_t">Brain Resuscitation Clinical Trial I Study Group. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 1986; 314:397.</a></li><li><a class="nounderline abstract_t">Jastremski M, Sutton-Tyrrell K, Vaagenes P, et al. Glucocorticoid treatment does not improve neurological recovery following cardiac arrest. Brain Resuscitation Clinical Trial I Study Group. JAMA 1989; 262:3427.</a></li><li><a class="nounderline abstract_t">Brain Resuscitation Clinical Trial II Study Group. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest. N Engl J Med 1991; 324:1225.</a></li><li><a class="nounderline abstract_t">Roine RO, Kaste M, Kinnunen A, et al. Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial. JAMA 1990; 264:3171.</a></li><li><a class="nounderline abstract_t">Thel MC, Armstrong AL, McNulty SE, et al. Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet 1997; 350:1272.</a></li><li><a class="nounderline abstract_t">Longstreth WT Jr, Fahrenbruch CE, Olsufka M, et al. Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest. Neurology 2002; 59:506.</a></li><li><a class="nounderline abstract_t">Olasveengen TM, Sunde K, Brunborg C, et al. Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial. JAMA 2009; 302:2222.</a></li><li><a class="nounderline abstract_t">Mody P, Brown SP, Kudenchuk PJ, et al. Intraosseous versus intravenous access in patients with out-of-hospital cardiac arrest: Insights from the resuscitation outcomes consortium continuous chest compression trial. Resuscitation 2019; 134:69.</a></li><li><a class="nounderline abstract_t">Daya MR, Leroux BG, Dorian P, et al. Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest. Circulation 2020; 141:188.</a></li><li><a class="nounderline abstract_t">Nolan JP, Deakin CD, Ji C, et al. Intraosseous versus intravenous administration of adrenaline in patients with out-of-hospital cardiac arrest: a secondary analysis of the PARAMEDIC2 placebo-controlled trial. Intensive Care Med 2020; 46:954.</a></li><li><a class="nounderline abstract_t">Hsieh YL, Wu MC, Wolfshohl J, et al. Intraosseous versus intravenous vascular access during cardiopulmonary resuscitation for out-of-hospital cardiac arrest: a systematic review and meta-analysis of observational studies. Scand J Trauma Resusc Emerg Med 2021; 29:44.</a></li><li><a class="nounderline abstract_t">Plaisance P, Soleil C, Lurie KG, et al. Use of an inspiratory impedance threshold device on a facemask and endotracheal tube to reduce intrathoracic pressures during the decompression phase of active compression-decompression cardiopulmonary resuscitation. Crit Care Med 2005; 33:990.</a></li><li><a class="nounderline abstract_t">Plaisance P, Lurie KG, Vicaut E, et al. Evaluation of an impedance threshold device in patients receiving active compression-decompression cardiopulmonary resuscitation for out of hospital cardiac arrest. Resuscitation 2004; 61:265.</a></li><li><a class="nounderline abstract_t">Aufderheide TP, Nichol G, Rea TD, et al. A trial of an impedance threshold device in out-of-hospital cardiac arrest. N Engl J Med 2011; 365:798.</a></li><li><a class="nounderline abstract_t">Lindner KH, Pfenninger EG, Lurie KG, et al. Effects of active compression-decompression resuscitation on myocardial and cerebral blood flow in pigs. Circulation 1993; 88:1254.</a></li><li><a class="nounderline abstract_t">Tucker KJ, Redberg RF, Schiller NB, Cohen TJ. Active compression-decompression resuscitation: analysis of transmitral flow and left ventricular volume by transesophageal echocardiography in humans. Cardiopulmonary Resuscitation Working Group. J Am Coll Cardiol 1993; 22:1485.</a></li><li><a class="nounderline abstract_t">Cohen TJ, Goldner BG, Maccaro PC, et al. A comparison of active compression-decompression cardiopulmonary resuscitation with standard cardiopulmonary resuscitation for cardiac arrests occurring in the hospital. N Engl J Med 1993; 329:1918.</a></li><li><a class="nounderline abstract_t">Lafuente-Lafuente C, Melero-Bascones M. Active chest compression-decompression for cardiopulmonary resuscitation. Cochrane Database Syst Rev 2013; :CD002751.</a></li><li><a class="nounderline abstract_t">Aufderheide TP, Frascone RJ, Wayne MA, et al. Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: a randomised trial. Lancet 2011; 377:301.</a></li><li><a class="nounderline abstract_t">Khan SU, Lone AN, Talluri S, et al. Efficacy and safety of mechanical versus manual compression in cardiac arrest - A Bayesian network meta-analysis. Resuscitation 2018; 130:182.</a></li><li><a class="nounderline abstract_t">Wroe PC, Clattenburg EJ, Gardner K, et al. Emergency department use of a mechanical chest compression device frequently causes unanticipated interruptions in cardiopulmonary resuscitation. Resuscitation 2018; 133:e3.</a></li><li><a class="nounderline abstract_t">William P, Rao P, Kanakadandi UB, et al. Mechanical Cardiopulmonary Resuscitation In and On the Way to the Cardiac Catheterization Laboratory. Circ J 2016; 80:1292.</a></li><li><a class="nounderline abstract_t">Venturini JM, Retzer E, Estrada JR, et al. Mechanical chest compressions improve rate of return of spontaneous circulation and allow for initiation of percutaneous circulatory support during cardiac arrest in the cardiac catheterization laboratory. Resuscitation 2017; 115:56.</a></li><li><a class="nounderline abstract_t">Rubertsson S, Lindgren E, Smekal D, et al. Mechanical chest compressions and simultaneous defibrillation vs conventional cardiopulmonary resuscitation in out-of-hospital cardiac arrest: the LINC randomized trial. JAMA 2014; 311:53.</a></li><li><a class="nounderline abstract_t">Wik L, Olsen JA, Persse D, et al. Manual vs. integrated automatic load-distributing band CPR with equal survival after out of hospital cardiac arrest. The randomized CIRC trial. Resuscitation 2014; 85:741.</a></li><li><a class="nounderline abstract_t">Perkins GD, Lall R, Quinn T, et al. Mechanical versus manual chest compression for out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised controlled trial. Lancet 2015; 385:947.</a></li><li><a class="nounderline abstract_t">Ward KR, Sullivan RJ, Zelenak RR, Summer WR. A comparison of interposed abdominal compression CPR and standard CPR by monitoring end-tidal PCO2. Ann Emerg Med 1989; 18:831.</a></li><li><a class="nounderline abstract_t">Babbs CF. Interposed abdominal compression CPR: a comprehensive evidence based review. Resuscitation 2003; 59:71.</a></li><li><a class="nounderline abstract_t">Waldman PJ, Walters BL, Grunau CF. Pancreatic injury associated with interposed abdominal compressions in pediatric cardiopulmonary resuscitation. Am J Emerg Med 1984; 2:510.</a></li><li><a class="nounderline abstract_t">Sack JB, Kesselbrenner MB, Jarrad A. Interposed abdominal compression-cardiopulmonary resuscitation and resuscitation outcome during asystole and electromechanical dissociation. Circulation 1992; 86:1692.</a></li><li><a class="nounderline abstract_t">Babbs CF. Simplified meta-analysis of clinical trials in resuscitation. Resuscitation 2003; 57:245.</a></li><li><a class="nounderline abstract_t">Sack JB, Kesselbrenner MB, Bregman D. Survival from in-hospital cardiac arrest with interposed abdominal counterpulsation during cardiopulmonary resuscitation. JAMA 1992; 267:379.</a></li><li><a class="nounderline abstract_t">Mateer JR, Stueven HA, Thompson BM, et al. Pre-hospital IAC-CPR versus standard CPR: paramedic resuscitation of cardiac arrests. Am J Emerg Med 1985; 3:143.</a></li><li><a class="nounderline abstract_t">Jabre P, Penaloza A, Pinero D, et al. Effect of Bag-Mask Ventilation vs Endotracheal Intubation During Cardiopulmonary Resuscitation on Neurological Outcome After Out-of-Hospital Cardiorespiratory Arrest: A Randomized Clinical Trial. JAMA 2018; 319:779.</a></li><li><a class="nounderline abstract_t">Benger JR, Kirby K, Black S, et al. Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest on Functional Outcome: The AIRWAYS-2 Randomized Clinical Trial. JAMA 2018; 320:779.</a></li><li><a class="nounderline abstract_t">Wang HE, Schmicker RH, Daya MR, et al. Effect of a Strategy of Initial Laryngeal Tube Insertion vs Endotracheal Intubation on 72-Hour Survival in Adults With Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA 2018; 320:769.</a></li><li><a class="nounderline abstract_t">Paris PM, Stewart RD, Kaplan RM, Whipkey R. Transcutaneous pacing for bradyasystolic cardiac arrests in prehospital care. Ann Emerg Med 1985; 14:320.</a></li><li><a class="nounderline abstract_t">Dalsey WC, Syverud SA, Hedges JR. Emergency department use of transcutaneous pacing for cardiac arrests. Crit Care Med 1985; 13:399.</a></li><li><a class="nounderline abstract_t">Hedges JR, Syverud SA, Dalsey WC, et al. Prehospital trial of emergency transcutaneous cardiac pacing. Circulation 1987; 76:1337.</a></li><li><a class="nounderline abstract_t">Rosenthal E, Thomas N, Quinn E, et al. Transcutaneous pacing for cardiac emergencies. Pacing Clin Electrophysiol 1988; 11:2160.</a></li><li><a class="nounderline abstract_t">Barthell E, Troiano P, Olson D, et al. Prehospital external cardiac pacing: a prospective, controlled clinical trial. Ann Emerg Med 1988; 17:1221.</a></li><li><a class="nounderline abstract_t">Cummins RO, Graves JR, Larsen MP, et al. Out-of-hospital transcutaneous pacing by emergency medical technicians in patients with asystolic cardiac arrest. N Engl J Med 1993; 328:1377.</a></li><li><a class="nounderline abstract_t">Sherbino J, Verbeek PR, MacDonald RD, et al. Prehospital transcutaneous cardiac pacing for symptomatic bradycardia or bradyasystolic cardiac arrest: a systematic review. Resuscitation 2006; 70:193.</a></li></ol></div><div id="topicVersionRevision">Topic 280 Version 36.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33081529" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33773825" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : European Resuscitation Council Guidelines 2021: Adult advanced life support.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33099419" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1522840" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : High-dose epinephrine in adult cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1433686" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30021076" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32981529" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Cost-effectiveness of adrenaline for out-of-hospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30658877" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Standard dose epinephrine versus placebo in out of hospital cardiac arrest: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30571262" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : 2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10486418" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11907287" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27043165" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23860985" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34587236" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Effect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35490936" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Effect of vasopressin and methylprednisolone vs. placebo on long-term outcomes in patients with in-hospital cardiac arrest a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37543161" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Vasopressin and methylprednisolone and hemodynamics after in-hospital cardiac arrest - A post hoc analysis of the VAM-IHCA trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37939521" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Efficacy and safety of corticosteroid therapy in patients with cardiac arrest: A meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20956224" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33849429" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Use of sodium bicarbonate in out-of-hospital cardiac arrest: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34847226" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Effect of Intravenous or Intraosseous Calcium vs Saline on Return of Spontaneous Circulation in Adults With Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31790759" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Beta-blockade for the treatment of cardiac arrest due to ventricular fibrillation or pulseless ventricular tachycardia: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2026986" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cause of death in unsuccessful prehospital resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9171064" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Immediate coronary angiography in survivors of out-of-hospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11377646" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31594741" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Can Systemic Thrombolysis Improve Prognosis of Cardiac Arrest Patients During Cardiopulmonary Resuscitation? A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19092151" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Thrombolysis during resuscitation for out-of-hospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12015391" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Tissue plasminogen activator in cardiac arrest with pulseless electrical activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16442386" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Effects of thrombolysis during out-of-hospital cardiopulmonary resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15135188" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Long-term survival and neurological outcome of patients who received recombinant tissue plasminogen activator during out-of-hospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2868412" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2685382" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Glucocorticoid treatment does not improve neurological recovery following cardiac arrest. Brain Resuscitation Clinical Trial I Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2014035" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2255026" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9357406" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12196641" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19934423" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30391366" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Intraosseous versus intravenous access in patients with out-of-hospital cardiac arrest: Insights from the resuscitation outcomes consortium continuous chest compression trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31941354" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32002593" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Intraosseous versus intravenous administration of adrenaline in patients with out-of-hospital cardiac arrest: a secondary analysis of the PARAMEDIC2 placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33685486" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Intraosseous versus intravenous vascular access during cardiopulmonary resuscitation for out-of-hospital cardiac arrest: a systematic review and meta-analysis of observational studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15891326" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Use of an inspiratory impedance threshold device on a facemask and endotracheal tube to reduce intrathoracic pressures during the decompression phase of active compression-decompression cardiopulmonary resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15172704" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Evaluation of an impedance threshold device in patients receiving active compression-decompression cardiopulmonary resuscitation for out of hospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21879897" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A trial of an impedance threshold device in out-of-hospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8353887" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Effects of active compression-decompression resuscitation on myocardial and cerebral blood flow in pigs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8227809" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Active compression-decompression resuscitation: analysis of transmitral flow and left ventricular volume by transesophageal echocardiography in humans. Cardiopulmonary Resuscitation Working Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8018138" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A comparison of active compression-decompression cardiopulmonary resuscitation with standard cardiopulmonary resuscitation for cardiac arrests occurring in the hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24052483" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Active chest compression-decompression for cardiopulmonary resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21251705" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: a randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29746986" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Efficacy and safety of mechanical versus manual compression in cardiac arrest - A Bayesian network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30244046" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Emergency department use of a mechanical chest compression device frequently causes unanticipated interruptions in cardiopulmonary resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27180892" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Mechanical Cardiopulmonary Resuscitation In and On the Way to the Cardiac Catheterization Laboratory.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28377296" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Mechanical chest compressions improve rate of return of spontaneous circulation and allow for initiation of percutaneous circulatory support during cardiac arrest in the cardiac catheterization laboratory.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24240611" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Mechanical chest compressions and simultaneous defibrillation vs conventional cardiopulmonary resuscitation in out-of-hospital cardiac arrest: the LINC randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24642406" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Manual vs. integrated automatic load-distributing band CPR with equal survival after out of hospital cardiac arrest. The randomized CIRC trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25467566" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Mechanical versus manual chest compression for out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2502937" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A comparison of interposed abdominal compression CPR and standard CPR by monitoring end-tidal PCO2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14580736" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Interposed abdominal compression CPR: a comprehensive evidence based review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6397200" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Pancreatic injury associated with interposed abdominal compressions in pediatric cardiopulmonary resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1451240" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Interposed abdominal compression-cardiopulmonary resuscitation and resuscitation outcome during asystole and electromechanical dissociation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12804802" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Simplified meta-analysis of clinical trials in resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1727961" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Survival from in-hospital cardiac arrest with interposed abdominal counterpulsation during cardiopulmonary resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3970769" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Pre-hospital IAC-CPR versus standard CPR: paramedic resuscitation of cardiac arrests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29486039" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Effect of Bag-Mask Ventilation vs Endotracheal Intubation During Cardiopulmonary Resuscitation on Neurological Outcome After Out-of-Hospital Cardiorespiratory Arrest: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30167701" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest on Functional Outcome: The AIRWAYS-2 Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30167699" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Effect of a Strategy of Initial Laryngeal Tube Insertion vs Endotracheal Intubation on 72-Hour Survival in Adults With Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3885803" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Transcutaneous pacing for bradyasystolic cardiac arrests in prehospital care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3987317" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Emergency department use of transcutaneous pacing for cardiac arrests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3315295" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Prehospital trial of emergency transcutaneous cardiac pacing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2463603" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Transcutaneous pacing for cardiac emergencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3056132" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Prehospital external cardiac pacing: a prospective, controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8474514" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Out-of-hospital transcutaneous pacing by emergency medical technicians in patients with asystolic cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16814446" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Prehospital transcutaneous cardiac pacing for symptomatic bradycardia or bradyasystolic cardiac arrest: a systematic review.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
